DYN — DYNE THERAPEUTICS INC

Ownership history in TWINBEECH CAPITAL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which TWINBEECH CAPITAL LP reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.04%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 115,341 -81,807 -41.5% 0.06% $1.5M $12.65
2025 Q2 ADDED 197,148 +138,623 +236.9% 0.04% $1.9M $9.52
2025 Q1 INITIATED 58,525 — — 0.01% $612K $10.46
% of Fund (quarterly)    DYN price (monthly, adj. close)

Other funds also holding DYN

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 20.64% FCPM III SERVICES B.V. 14.01% Saturn V Capital Management LP 3Y 6.42% Palo Alto Investors LP 3Y 7Y 4.01% Vivo Capital, LLC 3Y 7Y 3.31% MPM BioImpact LLC 3Y 3.15% TCG Crossover Management, LLC 3Y 2.99% STEMPOINT CAPITAL LP 2.8% VR Adviser, LLC 3Y 2.1% Siren, L.L.C. 2.04%
← Back to TWINBEECH CAPITAL LP Holdings